GlaxoSmithKline Consumer Nigeria plc has announced a dividend of Naira 0.5 per share

Declaration date: 08/03/2019

Record date: 23/04/2019

Pay date: 24/05/2019

Ex dividend date: 23/04/2019

For year end date: 31/12/2018

Period end date: 31/12/2018

Gross dividend: 0.5

Net dividend: 0.45

Marker: FNL

Frequency: SMA

Tax rate: 10

About the company

Glaxosmithkline Consumer Nigeria Plc manufactures and markets a range of consumer healthcare and pharmaceutical products in Nigeria. Its product portfolio includes treatments for asthma, HIV/AIDS, malaria, depression, migraines, diabetes, heart failure, digestive ailments and cancer. Consumer healthcare products include oral healthcare products; wellness products for the management of pain, gastro-intestinal and respiratory conditions; multivitamins; and a range of nutritional healthcare beverages. Glaxosmithkline Consumer Nigeria Plc produces a range of antibacterial products and vaccines to protect against illnesses such as hepatitis A and B, diphtheria, tetanus, whooping cough, typhoid, influenza and cervical cancer. The company was formerly known as Beecham Limited. Its head office is in Lagos, Nigeria.